Ondansetron Tablet, Film Coated
Product Images NDC 63304-459

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 63304-459). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron 1

Chemical structure of ondansetron hydrochloride dihydrate, the active ingredient in the ondansetron tablet, film coated formulation by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Ondansetron 2

Ondansetron Tablets, USP 4 mg film-coated tablets in a 30-tablet package from Sun Pharmaceutical Industries, Inc. The label indicates each tablet contains 4 mg of ondansetron hydrochloride dihydrate equivalent to 4 mg of ondansetron. Storage instructions and manufacturer/distributor information are also shown. This is an oral prescription drug.*

FDA Label Image

Ondansetron 3

Ondansetron Tablets, USP 8 mg film-coated tablets label from Sun Pharmaceutical Industries, Inc. The label indicates a package containing 30 tablets for oral use. It includes storage instructions, dosage equivalence, and regulatory information with barcodes and lot numbers visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.